USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like Large-Scale Additive Manufacturing – Release the KRAKEN October 26, 2017 Siemens Summit Touts Digital Twins and Transformations July 2, 2019 Drone Show Illuminates Additive Manufacturing October 22, 2018